par Desmedt, Christine 
;Di Leo, Angelo ;de Azambuja, Evandro ;Larsimont, Denis ;Haibe-Kains, Benjamin ;Selleslags, Jean;Delaloge, Suzette;Duhem, Caroline;Kains, Jean-Pierre;Carly, Birgit;Maerevoet, Marie ;Vindevoghel, Anita;Rouas, Ghizlane;Lallemand, Françoise;Durbecq, Virginie ;Cardoso, Fatima ;Salgado, Roberto;Kraft Rovere, Rodrigo ;Bontempi, Gianluca ;Michiels, Stefan ;Buyse, Marc;Nogaret, Jean-Marie ;Qi, Yuan;Symmans, Fraser;Pusztai, Lajos;D'Hondt, Veronique ;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence Journal of clinical oncology, 29, 12, page (1578-1586)
Publication Publié, 2011-04
;Di Leo, Angelo ;de Azambuja, Evandro ;Larsimont, Denis ;Haibe-Kains, Benjamin ;Selleslags, Jean;Delaloge, Suzette;Duhem, Caroline;Kains, Jean-Pierre;Carly, Birgit;Maerevoet, Marie ;Vindevoghel, Anita;Rouas, Ghizlane;Lallemand, Françoise;Durbecq, Virginie ;Cardoso, Fatima ;Salgado, Roberto;Kraft Rovere, Rodrigo ;Bontempi, Gianluca ;Michiels, Stefan ;Buyse, Marc;Nogaret, Jean-Marie ;Qi, Yuan;Symmans, Fraser;Pusztai, Lajos;D'Hondt, Veronique ;Piccart-Gebhart, Martine ;Sotiriou, Christos Référence Journal of clinical oncology, 29, 12, page (1578-1586)
Publication Publié, 2011-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Desmedt, Christine; Di Leo, Angelo; de Azambuja, Evandro; Larsimont, Denis; Haibe-Kains, Benjamin; Selleslags, Jean; Delaloge, Suzette; Duhem, Caroline; Kains, Jean-Pierre; Carly, Birgit; Maerevoet, Marie; Vindevoghel, Anita; Rouas, Ghizlane; Lallemand, Françoise; Durbecq, Virginie; Cardoso, Fatima; Salgado, Roberto; Kraft Rovere, Rodrigo; Bontempi, Gianluca; Michiels, Stefan; Buyse, Marc; Nogaret, Jean-Marie; Qi, Yuan; Symmans, Fraser; Pusztai, Lajos; D'Hondt, Veronique; Piccart-Gebhart, Martine; Sotiriou, Christos |
| Informations sur la publication: | Journal of clinical oncology, 29, 12, page (1578-1586) |
| Statut de publication: | Publié, 2011-04 |
| Sujet CREF: | Cancérologie |
| Sciences biomédicales | |
| MeSH keywords: | Antibiotics, Antineoplastic -- adverse effects -- therapeutic use |
| Antigens, Neoplasm -- analysis -- genetics | |
| Biopsy | |
| Breast Neoplasms -- drug therapy -- enzymology -- genetics -- pathology | |
| Chemotherapy, Adjuvant | |
| DNA Topoisomerases, Type II -- analysis -- genetics | |
| DNA-Binding Proteins -- analysis -- antagonists & inhibitors -- genetics | |
| Drug Resistance, Neoplasm -- genetics | |
| Epirubicin -- adverse effects -- therapeutic use | |
| Europe | |
| Female | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Middle Aged | |
| Neoadjuvant Therapy | |
| Odds Ratio | |
| Patient Selection | |
| Predictive Value of Tests | |
| Prospective Studies | |
| Receptor, erbB-2 -- analysis | |
| Receptors, Estrogen -- analysis | |
| Reproducibility of Results | |
| Risk Assessment | |
| Risk Factors | |
| Texas | |
| Treatment Failure | |
| Tumor Markers, Biological -- analysis | |
| Note générale: | Journal Article |
| Multicenter Study | |
| Randomized Controlled Trial | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2010.31.2231 | |
| info:pii/JCO.2010.31.2231 | |
| info:scp/79955008762 | |
| info:pmid/21422418 |
